Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOD-4023 Dose Finding in Pediatric GHD
NCT01592500Phase 2Completed
- Sponsor
- OPKO Health
- Start
- Feb 2012
- Primary completion
- Jul 2015
- Modality
- Fc-Fusion Proteins
- Countries
- 3
01
Overview
A Phase 2 trial of somatrogon in growth hormone deficiency (GHD), sponsored by OPKO Health. Started Feb 2012; status: completed.
02
Drugs
somatrogon
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on NCT01592500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01592500.